PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
23116317-0	2013	Promising curcumin-based drug design: mono-carbonyl analogues of curcumin (MACs).	Curcumin	10-18	myristoylated alanine rich protein kinase C substrate	Homo sapiens	75-79	
23116317-0	2013	Promising curcumin-based drug design: mono-carbonyl analogues of curcumin (MACs).	Curcumin	65-73	myristoylated alanine rich protein kinase C substrate	Homo sapiens	75-79	
23116317-7	2013	Particularly, the latter called mono-carbonyl analogs of curcumin (MACs) has been reported to has an enhanced stability in vitro and an improved pharmacokinetic profile in vivo.	Curcumin	57-65	myristoylated alanine rich protein kinase C substrate	Homo sapiens	67-71	
23116317-8	2013	Thus, MACs have attracted a high attention for development of new curcumin-based agents with both enhanced bioactivities and pharmacokinetic profiles.	Curcumin	66-74	myristoylated alanine rich protein kinase C substrate	Homo sapiens	6-10